Home Healthcare Pharmaceuticals Gastroparesis Drugs Market

Gastroparesis Drugs Market Size, Share & Trends Analysis Report By Drug Class (Prokinetic Agents, Antiemetic Agents, Botulinum Toxin Injections), By Disease Type (Diabetic Gastroparesis, Idiopathic Gastroparesis, Post-surgical Gastroparesis, Others), By End-User (Hospitals, Pharmacies, Clinics) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: June 03, 2026 | Author: Mitiksha Koul | Format: | Report Code: SR5870DR | Pages: 110
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Gastroparesis Drugs Market, By Drug Class 2022-2034 (USD MILLION/ Units)
    1. Prokinetic Agents
    2. Antiemetic Agents
    3. Botulinum Toxin Injections
  2. Gastroparesis Drugs Market, By Disease Type 2022-2034 (USD MILLION/ Units)
    1. Diabetic Gastroparesis
    2. Idiopathic Gastroparesis
    3. Post-surgical Gastroparesis
    4. Others
  3. Gastroparesis Drugs Market, By End-User 2022-2034 (USD MILLION/ Units)
    1. Hospitals
    2. Pharmacies
    3. Clinics
  4. Regional Gastroparesis Drugs Market
    1. North America
      1. North America Gastroparesis Drugs Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Prokinetic Agents
        2. Antiemetic Agents
        3. Botulinum Toxin Injections
      2. North America Gastroparesis Drugs Market By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Diabetic Gastroparesis
        2. Idiopathic Gastroparesis
        3. Post-surgical Gastroparesis
        4. Others
      3. North America Gastroparesis Drugs Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Pharmacies
        3. Clinics
      4. U.S.
        1. Prokinetic Agents
        2. Antiemetic Agents
        3. Botulinum Toxin Injections
        4. Diabetic Gastroparesis
        5. Idiopathic Gastroparesis
        6. Post-surgical Gastroparesis
        7. Others
        8. Hospitals
        9. Pharmacies
        10. Clinics
      5. Canada
        1. Prokinetic Agents
        2. Antiemetic Agents
        3. Botulinum Toxin Injections
        4. Diabetic Gastroparesis
        5. Idiopathic Gastroparesis
        6. Post-surgical Gastroparesis
        7. Others
        8. Hospitals
        9. Pharmacies
        10. Clinics
    2. Europe
      1. Europe Gastroparesis Drugs Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Prokinetic Agents
        2. Antiemetic Agents
        3. Botulinum Toxin Injections
      2. Europe Gastroparesis Drugs Market By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Diabetic Gastroparesis
        2. Idiopathic Gastroparesis
        3. Post-surgical Gastroparesis
        4. Others
      3. Europe Gastroparesis Drugs Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Pharmacies
        3. Clinics
      4. U.K.
        1. Prokinetic Agents
        2. Antiemetic Agents
        3. Botulinum Toxin Injections
        4. Diabetic Gastroparesis
        5. Idiopathic Gastroparesis
        6. Post-surgical Gastroparesis
        7. Others
        8. Hospitals
        9. Pharmacies
        10. Clinics
      5. Germany
        1. Prokinetic Agents
        2. Antiemetic Agents
        3. Botulinum Toxin Injections
        4. Diabetic Gastroparesis
        5. Idiopathic Gastroparesis
        6. Post-surgical Gastroparesis
        7. Others
        8. Hospitals
        9. Pharmacies
        10. Clinics
      6. France
        1. Prokinetic Agents
        2. Antiemetic Agents
        3. Botulinum Toxin Injections
        4. Diabetic Gastroparesis
        5. Idiopathic Gastroparesis
        6. Post-surgical Gastroparesis
        7. Others
        8. Hospitals
        9. Pharmacies
        10. Clinics
      7. Spain
        1. Prokinetic Agents
        2. Antiemetic Agents
        3. Botulinum Toxin Injections
        4. Diabetic Gastroparesis
        5. Idiopathic Gastroparesis
        6. Post-surgical Gastroparesis
        7. Others
        8. Hospitals
        9. Pharmacies
        10. Clinics
      8. Italy
        1. Prokinetic Agents
        2. Antiemetic Agents
        3. Botulinum Toxin Injections
        4. Diabetic Gastroparesis
        5. Idiopathic Gastroparesis
        6. Post-surgical Gastroparesis
        7. Others
        8. Hospitals
        9. Pharmacies
        10. Clinics
      9. Russia
        1. Prokinetic Agents
        2. Antiemetic Agents
        3. Botulinum Toxin Injections
        4. Diabetic Gastroparesis
        5. Idiopathic Gastroparesis
        6. Post-surgical Gastroparesis
        7. Others
        8. Hospitals
        9. Pharmacies
        10. Clinics
      10. Nordic
        1. Prokinetic Agents
        2. Antiemetic Agents
        3. Botulinum Toxin Injections
        4. Diabetic Gastroparesis
        5. Idiopathic Gastroparesis
        6. Post-surgical Gastroparesis
        7. Others
        8. Hospitals
        9. Pharmacies
        10. Clinics
      11. Benelux
        1. Prokinetic Agents
        2. Antiemetic Agents
        3. Botulinum Toxin Injections
        4. Diabetic Gastroparesis
        5. Idiopathic Gastroparesis
        6. Post-surgical Gastroparesis
        7. Others
        8. Hospitals
        9. Pharmacies
        10. Clinics
      12. Rest of Europe
        1. Prokinetic Agents
        2. Antiemetic Agents
        3. Botulinum Toxin Injections
        4. Diabetic Gastroparesis
        5. Idiopathic Gastroparesis
        6. Post-surgical Gastroparesis
        7. Others
        8. Hospitals
        9. Pharmacies
        10. Clinics
    3. APAC
      1. APAC Gastroparesis Drugs Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Prokinetic Agents
        2. Antiemetic Agents
        3. Botulinum Toxin Injections
      2. APAC Gastroparesis Drugs Market By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Diabetic Gastroparesis
        2. Idiopathic Gastroparesis
        3. Post-surgical Gastroparesis
        4. Others
      3. APAC Gastroparesis Drugs Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Pharmacies
        3. Clinics
      4. China
        1. Prokinetic Agents
        2. Antiemetic Agents
        3. Botulinum Toxin Injections
        4. Diabetic Gastroparesis
        5. Idiopathic Gastroparesis
        6. Post-surgical Gastroparesis
        7. Others
        8. Hospitals
        9. Pharmacies
        10. Clinics
      5. Korea
        1. Prokinetic Agents
        2. Antiemetic Agents
        3. Botulinum Toxin Injections
        4. Diabetic Gastroparesis
        5. Idiopathic Gastroparesis
        6. Post-surgical Gastroparesis
        7. Others
        8. Hospitals
        9. Pharmacies
        10. Clinics
      6. Japan
        1. Prokinetic Agents
        2. Antiemetic Agents
        3. Botulinum Toxin Injections
        4. Diabetic Gastroparesis
        5. Idiopathic Gastroparesis
        6. Post-surgical Gastroparesis
        7. Others
        8. Hospitals
        9. Pharmacies
        10. Clinics
      7. India
        1. Prokinetic Agents
        2. Antiemetic Agents
        3. Botulinum Toxin Injections
        4. Diabetic Gastroparesis
        5. Idiopathic Gastroparesis
        6. Post-surgical Gastroparesis
        7. Others
        8. Hospitals
        9. Pharmacies
        10. Clinics
      8. Australia
        1. Prokinetic Agents
        2. Antiemetic Agents
        3. Botulinum Toxin Injections
        4. Diabetic Gastroparesis
        5. Idiopathic Gastroparesis
        6. Post-surgical Gastroparesis
        7. Others
        8. Hospitals
        9. Pharmacies
        10. Clinics
      9. Singapore
        1. Prokinetic Agents
        2. Antiemetic Agents
        3. Botulinum Toxin Injections
        4. Diabetic Gastroparesis
        5. Idiopathic Gastroparesis
        6. Post-surgical Gastroparesis
        7. Others
        8. Hospitals
        9. Pharmacies
        10. Clinics
      10. Taiwan
        1. Prokinetic Agents
        2. Antiemetic Agents
        3. Botulinum Toxin Injections
        4. Diabetic Gastroparesis
        5. Idiopathic Gastroparesis
        6. Post-surgical Gastroparesis
        7. Others
        8. Hospitals
        9. Pharmacies
        10. Clinics
      11. South East Asia
        1. Prokinetic Agents
        2. Antiemetic Agents
        3. Botulinum Toxin Injections
        4. Diabetic Gastroparesis
        5. Idiopathic Gastroparesis
        6. Post-surgical Gastroparesis
        7. Others
        8. Hospitals
        9. Pharmacies
        10. Clinics
      12. Rest of Asia-Pacific
        1. Prokinetic Agents
        2. Antiemetic Agents
        3. Botulinum Toxin Injections
        4. Diabetic Gastroparesis
        5. Idiopathic Gastroparesis
        6. Post-surgical Gastroparesis
        7. Others
        8. Hospitals
        9. Pharmacies
        10. Clinics
    4. Middle East and Africa
      1. Middle East and Africa Gastroparesis Drugs Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Prokinetic Agents
        2. Antiemetic Agents
        3. Botulinum Toxin Injections
      2. Middle East and Africa Gastroparesis Drugs Market By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Diabetic Gastroparesis
        2. Idiopathic Gastroparesis
        3. Post-surgical Gastroparesis
        4. Others
      3. Middle East and Africa Gastroparesis Drugs Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Pharmacies
        3. Clinics
      4. UAE
        1. Prokinetic Agents
        2. Antiemetic Agents
        3. Botulinum Toxin Injections
        4. Diabetic Gastroparesis
        5. Idiopathic Gastroparesis
        6. Post-surgical Gastroparesis
        7. Others
        8. Hospitals
        9. Pharmacies
        10. Clinics
      5. Turkey
        1. Prokinetic Agents
        2. Antiemetic Agents
        3. Botulinum Toxin Injections
        4. Diabetic Gastroparesis
        5. Idiopathic Gastroparesis
        6. Post-surgical Gastroparesis
        7. Others
        8. Hospitals
        9. Pharmacies
        10. Clinics
      6. Saudi Arabia
        1. Prokinetic Agents
        2. Antiemetic Agents
        3. Botulinum Toxin Injections
        4. Diabetic Gastroparesis
        5. Idiopathic Gastroparesis
        6. Post-surgical Gastroparesis
        7. Others
        8. Hospitals
        9. Pharmacies
        10. Clinics
      7. South Africa
        1. Prokinetic Agents
        2. Antiemetic Agents
        3. Botulinum Toxin Injections
        4. Diabetic Gastroparesis
        5. Idiopathic Gastroparesis
        6. Post-surgical Gastroparesis
        7. Others
        8. Hospitals
        9. Pharmacies
        10. Clinics
      8. Egypt
        1. Prokinetic Agents
        2. Antiemetic Agents
        3. Botulinum Toxin Injections
        4. Diabetic Gastroparesis
        5. Idiopathic Gastroparesis
        6. Post-surgical Gastroparesis
        7. Others
        8. Hospitals
        9. Pharmacies
        10. Clinics
      9. Nigeria
        1. Prokinetic Agents
        2. Antiemetic Agents
        3. Botulinum Toxin Injections
        4. Diabetic Gastroparesis
        5. Idiopathic Gastroparesis
        6. Post-surgical Gastroparesis
        7. Others
        8. Hospitals
        9. Pharmacies
        10. Clinics
      10. Rest of MEA
        1. Prokinetic Agents
        2. Antiemetic Agents
        3. Botulinum Toxin Injections
        4. Diabetic Gastroparesis
        5. Idiopathic Gastroparesis
        6. Post-surgical Gastroparesis
        7. Others
        8. Hospitals
        9. Pharmacies
        10. Clinics
    5. LATAM
      1. LATAM Gastroparesis Drugs Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Prokinetic Agents
        2. Antiemetic Agents
        3. Botulinum Toxin Injections
      2. LATAM Gastroparesis Drugs Market By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Diabetic Gastroparesis
        2. Idiopathic Gastroparesis
        3. Post-surgical Gastroparesis
        4. Others
      3. LATAM Gastroparesis Drugs Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Pharmacies
        3. Clinics
      4. Brazil
        1. Prokinetic Agents
        2. Antiemetic Agents
        3. Botulinum Toxin Injections
        4. Diabetic Gastroparesis
        5. Idiopathic Gastroparesis
        6. Post-surgical Gastroparesis
        7. Others
        8. Hospitals
        9. Pharmacies
        10. Clinics
      5. Mexico
        1. Prokinetic Agents
        2. Antiemetic Agents
        3. Botulinum Toxin Injections
        4. Diabetic Gastroparesis
        5. Idiopathic Gastroparesis
        6. Post-surgical Gastroparesis
        7. Others
        8. Hospitals
        9. Pharmacies
        10. Clinics
      6. Argentina
        1. Prokinetic Agents
        2. Antiemetic Agents
        3. Botulinum Toxin Injections
        4. Diabetic Gastroparesis
        5. Idiopathic Gastroparesis
        6. Post-surgical Gastroparesis
        7. Others
        8. Hospitals
        9. Pharmacies
        10. Clinics
      7. Chile
        1. Prokinetic Agents
        2. Antiemetic Agents
        3. Botulinum Toxin Injections
        4. Diabetic Gastroparesis
        5. Idiopathic Gastroparesis
        6. Post-surgical Gastroparesis
        7. Others
        8. Hospitals
        9. Pharmacies
        10. Clinics
      8. Colombia
        1. Prokinetic Agents
        2. Antiemetic Agents
        3. Botulinum Toxin Injections
        4. Diabetic Gastroparesis
        5. Idiopathic Gastroparesis
        6. Post-surgical Gastroparesis
        7. Others
        8. Hospitals
        9. Pharmacies
        10. Clinics
      9. Rest of LATAM
        1. Prokinetic Agents
        2. Antiemetic Agents
        3. Botulinum Toxin Injections
        4. Diabetic Gastroparesis
        5. Idiopathic Gastroparesis
        6. Post-surgical Gastroparesis
        7. Others
        8. Hospitals
        9. Pharmacies
        10. Clinics
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.